Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia*, Claudio Rapezzi, Yehuda Adler, Michael Arad, Cristina Basso, Antonio Brucato, Ivana Burazor, Alida L. P. Caforio, Thibaud Damy, Urs Eriksson, Marianna Fontana, Julian D. Gillmore, Esther Gonzalez-Lopez, Martha Grogan, Stephane Heymans, Massimo Imazio, Ingrid Kindermann, Arnt Kristen, Mathew S. Maurer, Giampaolo MerliniAntonis Pantazis, Sabine Pankuweit, Angelos G. Rigopoulos, Ales Linhart

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1554-1568
Number of pages15
JournalEuropean Heart Journal
Volume42
Issue number16
DOIs
Publication statusPublished - 21 Apr 2021

Keywords

  • Amyloidosis
  • Cardiac amyloidosis
  • Diagnosis
  • Treatment
  • AL
  • TTR
  • Transthyretin
  • TRANSTHYRETIN AMYLOIDOSIS
  • HEREDITARY
  • CARDIOMYOPATHY
  • MANAGEMENT
  • NOMENCLATURE
  • PREDICTORS

Cite this